Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714479 · ClinicalTrials.gov registry record · NA
Skeletal Muscle Response to Amino Acids and Load Carriage Exercise
A NA study, sponsored by United States Army Research Institute of Environmental Medicine.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01714479 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 40 participants.
The verdict
NCT01714479, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Warfighters often experience physical overload, as the uniform and associated gear that they carry burdens them with substantial loads. The loads increase energy expenditure to levels that exceed a Warfighter's typical energy intake. The typical assault load is approximately 25 kg, although loads as high as 55 kg are often carried, which when combined with extreme energy expenditures can degrade health and performance, and increase the risk of injury. Branched-chain amino acid (leucine) supplementation may confer protection against the negative effects of operational stress by stimulating muscle protein synthesis and reducing degradation. This study will determine if leucine-enriched nutrition supplementation confers protection against the negative consequences of sustained load carriage exercise, and explore the mechanisms by which leucine might impart protection.
Interventions
- OTHER Placebo
- OTHER Leucine-enriched nutritional supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714479
The ClinicalTrials.gov registry entry for NCT01714479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01714479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714479 about?
NCT01714479 is a clinical study titled "Skeletal Muscle Response to Amino Acids and Load Carriage Exercise". Warfighters often experience physical overload, as the uniform and associated gear that they carry burdens them with substantial loads. The loads increase energy expenditure to levels that exceed a Warfighter's typical energy intake. The typical assault load is approximately 25 kg, although loads as...
What is the current status of trial NCT01714479?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-10. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01714479?
The interventions under investigation include: Placebo (OTHER), Leucine-enriched nutritional supplement (OTHER).
Who is sponsoring clinical trial NCT01714479?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.